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Fiberoptically guided tracheal intubation represents one of the most important
advances in airway management to occur in the past thirty years. Perhaps its
most important role is in management ofthe anticipated difficult airway. This is
a situation in which the dangers ofencountering the life-threatening "can't intu-
bate, can't ventilate" situation can be avoided by placement of an endotracheal
tube while the patient is awake. Although skill at the procedure ofendoscopy is
obviously necessary in this setting, these authors hold that success or failure of
the technique frequently depends on the adequacy of preparation. These mea-
sures include 1) pre-operative assessment of the patient; 2) careful explanation
of what lies in store; 3) "setting the stage"; 4) preparing the equipment to be
used; and 5) preparing the patient (antisialogue, sedation, application oftopical
anesthesia to the upper airway). If these preparatory measures are carried out
meticulously, the likelihood ofperforming a successful and comfortable awake
fiberoptic tracheal intubation is greatly increased.
INTRODUCTION
Adverse outcomes associated with respiratory events constitute the single largest
class ofinjury associated with anesthesia. This was documented by TheAmerican Society
ofAnesthesiologists Closed Claims Study in which respiratory events accounted for 522
of 1541 injury cases (34 percent) [1]. The overall incidence ofdifficult intubation has been
estimated to be 1:2,000 in the general surgical population and 1:300 in the obstetric pop-
ulation [2]. In addition to the high prevalence of the problem, it is important because of
the associated likelihood ofbad outcome. Eighty-five per cent ofrespiratory management
failures resulted in death or brain damage [1].
Tracheal intubation using a "railroad" technique (i.e., advancing an endotracheal tube
over an endoscope that is positioned in the trachea) was first performed by Murphy et al.
in 1967 [3]. The most important indication for this technique is in the management ofthe
anticipated difficult airway in the co-operative patient. In this setting, the risk of loss of
upper airway patency during an inhalational induction is avoided. Other important indi-
cations include the patient with cervical spine injury and situations where a potentially
difficult airway management problem and the need to maintain spontaneous ventilation
coexist, e.g., bronchopleural fistulae. Learning to perform an awake fiberoptic intubation
requires practice and, in skilled hands, has a high degree ofpatient acceptability. The key
to success is thorough preparation.
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PRE-OPERATIVE ASSESSMENT
The likelihood ofperforming a successful fiberoptic intubation is greatly increased if
the reason for choosing this technique is explained to the patient in a detailed and unhur-
ried fashion. The patient should be given a thorough description ofwhat to expect. Awake
fiberoptic intubation will proceed more easily in the well-informed, co-operative patient
who understands the procedure. Specific instructions should be explained/illustrated to the
patient, for example, not to speak during the intubation, to raise a hand if he/she would
like the endoscopist to withdraw, to take deep breaths or to "pant."
In addition to a thorough anesthetic history and physical examination, the patient
should be asked specifically about previous airway trauma or surgery and a history of
epistaxis or bleeding. Details of previous unsuccessful or difficult intubation attempts
should be sought from anesthetic records, and the anesthesiologist involved should be
contacted if necessary. An explanatory note on the reason difficulty was encountered, or
techniques which proved unsuccessful, are particularly useful. Although extremely rare,
knowledge ofpatient's allergies to local anesthetics should be sought [4]. Because topical
anesthesia is applied to the upper airway, the possibility of aspiration of gastric contents
has to be borne in mind. This is particularly true in those at increased risk; for example
the presence of a "full stomach," raised intra-abdominal pressure, hiatus hernia, etc.
The safety of performing an awake fiberoptic intubation in this group of patients is
controversial. Ovassapian has pointed out that, while the proximal airway (to the level of
the vocal cords) is anesthetized, the distal protective reflexes remain intact and will enable
the patient to cough forcibly ifforeign material should enter the trachea [5]. In practice, it
is necessary to individually balance the risks of pulmonary aspiration of gastric contents
with the benefits of the safety of performing an awake intubation in each case.
Administration of an H2 antagonist, a non-particulate antacid or a prokinetic agent should
be considered. Ranitidine (150 mg) orally in the average 70 kg patient is a common
choice. Alternatively, 50 mg intravenously infused over 15 minutes produces peak blood
levels in 60 to 90 minutes [6]. There are few contraindications to an awake fiberoptic intu-
bation; namely: patient refusal, an uncooperative patient (such as a child or a mentally
handicapped patient) or a true allergy to amide local anesthetics.
OPERATING ROOM PREPARATION: "SETTING THE STAGE"
The Difficult Airway Task Force (ASA-1992) emphasized that "preparatory efforts
enhance success and minimize risk to the patient" [7]. There should be at least one qual-
ified assistant to help manage the airway ifdifficulties arise. The assistant's functions are:
1. To observe the patient clinically.
2. To use standard monitoring during the endoscopy.
3. To administer intravenous sedatives.
4. To inject local anesthetic through the working channel ofthe fiberscope under
the direction ofthe endoscopists.
5. To optimize the position the patients head and neck.
6. To pass and receive the fiberscope.
A calm, quiet room is optimal; good lighting with the ability to dim if required is
desirable. A patient table, the height and tilt of which can be adjusted, should be used. A
foot stool for the endoscopist to stand on should be available to allow him/her to hold the
insertion cord ofthe fiberscope taut. This allows for consistent, accurate movement ofthe
fiberscope tip.
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Figure 1. Operating room set-up.
All equipment and supplies for administration of anesthesia, resuscitation and mon-
itoring should be available in the induction room and should be checked following a stan-
dard protocol. Basic intra-operative monitoring should include a precordial stethoscope,
ECG, non-invasive blood pressure, pulse oximetry and capnometry. Standard difficult
airway equipment should to be available and organized carefully on a separate mobile
trolley. This trolley should include the following:
1. Range of laryngoscopes.
2. Range ofendotracheal tubes.
3. Gum elastic bougies, Magill's forceps.
4. Retrograde intubation equipment (e.g., epidural catheter or guide wire).
-5. Laryngeal mask airway.
6. Combitube.
7. Cricothyroidotomy set and connections forjet ventilation.
This trolley should be readily accessible. The fiberoptic equipment should be posi-
tioned so that it can picked up easily by the endoscopist. It is important that care is taken
to avoid draping the camera cable or the light source cable across the patient's face. The
fiberscope should be stored in a vertical plastic holder to avoid coiling (Figure 1).
EQUIPMENT PREPARATION
The necessary equipment include a range oforal/nasal armored/regular tubes, a lubri-
cant, a defogging agent, lidocaine in its various forns (solution, gel, aerosol), cocaine 4
percent, oral intubation airways, soft nasopharyngeal airways, suction, needles, syringes,
pledgets, cotton-tipped applicators, tongue blade, epidural catheter, nebulizer, Krause for-
ceps and an appropriate sized laryngeal mask airway. The chosen endotracheal tube is
loaded over the lubricated fiberscope, having removed the 22 mm connector. The distal 20
cm of the insertion tube should be kept free of lubricant so that the endoscopist's gloved
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hand can grip and manipulate this portion. The connector should be placed in a secure
place for convenient reconnection. There are a number of oral intubating airways to
choose from. Each is designed to fulfill three functions:
1. To protect the fiberscope from injury ifthe patient were to bite down.
2. To direct the scope in the midline towards the vocal cords.
3. To displace the tongue posteriorly, out ofthe path ofthe fiberscope.
INTUBATING AIRWAYS
Patil-Syracuse intubating airway
This aluminum airway is only available in one size. There is a small central groove
on the lingual surface ofthis airway and a slit at the distal end. This slit allows for good
anteroposterior manipulation of the fiberscope tip, but lateral movement is limited [8]
(Figure 2).
Williams' intubating airway
The proximal halfofthis airway is cylindrical, and the distal halfhas an open lingual
surface. This airway is made in two sizes (90 and 100 mm I.D.) which admit endotracheal
tubes up to 8 and 8.5 mm I.D., respectively. If the distal end of this airway is not in line
with the glottis, exposure of the cords becomes difficult, necessitating partial withdrawal
ofthe airway (Figure 3).
Ovassapian intubating airway
This airway has a flat lingual surface in the proximal half, which minimizes move-
ment of the airway. The wide distal half curves to prevent the tongue and soft tissues of
the anterior pharyngeal wall from falling back and obstructing the view of the glottis. It
can accommodate an endotracheal tube up to 9.0 mm I.D. (Figure 4).
Figure 2. Patil-Syracuse intubating airway.
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Figure 3. Williams intubating airway.
Figure 4. Ovassapian intubating airway.
Figure 5. Olympus airway.
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Olympus Airway
This airway is better described as a bite block. It does not displace the tongue and
does not maintain the fiberscope in the midline. It does protect the fiberscope, and the
endotracheal tube can be passed through it (Figure 5).
The fiberoptic scope, light source and ancillary equipment are carefully inspected to
ensure that they are in proper working condition. Commonly used fiberoptic equipment is
listed in Table 1. Damage commonly occurs to the fiber bundles when the insertion tube
is sharply bent or trapped in a closing drawer. The insertion tube should be inspected for
dents and bulges and the angulation levermanipulated to ensure thatthe distal tip responds
appropriately.
PROCEDURES FOR USING THE VIDEO AIRWAY CART
1. Plug in the master power cord.
2. Turn on the VCR, light source, camera, monitor, and mavigraph.
3. Fiberoptic bronchoscope:
* Connect insertion cord to light source.
* Choose MANUAL light intensity adjuster.
* The light source intensity is adjusted to an adequate level of illumi-
nation.
* The minimum necessary light intensity is chosen to avoid thermal
mucosal damage.
* Hold tip in palm of left hand, eyepiece in right and focus using the
diopter ring. This is achieved by holding the fiberscope tip 6 mm
from written material and bringing this picture into focus.
* Connect oxygen 3-4 L/min to working channel. Orient the working
channel to lie underthe left index finger while the leftthumb controls
the angulation lever, thus leaving the right hand free to manipulate
the insertion tube.
* Connect a 10cc non-luer lock syringe of 1 percent lidocaine onto the
biopsy valve diaphragm if a "spray as you go" technique is planned.
Table 1. Characteristics offiberoptic bronchoscopes.
Insertion Insertion Working
cord diameter cord length channel Tip bending Field ofview
Instrument (mm) (mm) (mm) (degrees) (degrees)
Olympus
LF-2 4.0 600 1.5 Up 130/down 130 90
LF-P 2.2 600 None Up 120/down 120 75
Pentax
FB-1OX 3.5 600 1.2 Up 180/down 130 95
FB-15X 4.9 600 2.2 Up 180/down 130 100
VB-1530 5.5 600 1.2 Up 180/down 130 120
Adapted from Benumof. Airway management: principles and practice (with permission.)
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Ensure a new biopsy valve is snapped onto the biopsy port before
each use.
* Defog the tip. Dip the tip in defogger liquid once or twice and let it
dry.
* Alternatively, warm the fiberscope and fiber bundles in warm saline.
The lens should be wiped with a clean gauze lightly moistened with
70 percent alcohol.
* Place the endotracheal tube over the fiberscope and lightly secure it
with tape to the upper end ofthe insertion cord.
4. Video and Camera: A coupler is used to connect the camera to the fiber-
scope. Adjust the divot to 12 o'clock, ifyou are at the patient's head and
change it 3 o'clock ifyou are at the right side. This allows for correct ori-
entation of fiberscope tip. Focus the camera by twisting the diopter ring
just above the camera. (Note: this is a separate step from focusing the
bronchoscope itself). Olympus has developed an autofocus camera head
for use during endoscopy (OTV-S5 OES VIDEO SYSTEM). Most video
systems designed for use during endoscopy contain automatic resolution,
brightness and color controls.
SUCTION
If central wall suction is not available, an appropriate portable suction apparatus
should be part of the emergency airway trolley. Either a soft-tipped flexible suction
catheter or a stiffYankauer suction tip should be used for the oropharynx. In our experi-
ence, applying suction to the working channel of the commonly used Olympus LF2-
Fiberscope is ineffectual (I.D. of 1.5 mm), and it serves only to draw secretions towards
the object lens, obscuring the endoscopist's view.
OXYGENATION
Arterial hypoxemia has been well documented during bronchoscopy. The safety of
the procedure is enhanced by the use ofsupplemental oxygen. Nasal cannulae can be used
at 2-3 liters /minute if the oral route is chosen. When performing a nasal intubation, an
ordinary facemask can be modified by cutting out a window for the fiberscope.
Administration of oxygen or application of suction via the working channel can be alter-
nated as required using a 3-way stopcock. High flow rates (>5 L/min) are inadvisable
because they will result in gastric insufflation if the tip of the fiberscope inadvertently
enters the esophagus.
PHARMACOLOGICAL AIDS
Antisialogogues
A dry airway is desirable because secretions obscure an already limited view through
the scope. In order for topical application of local anesthetics to be effective, they must
actually contact the mucosa [9]. An intervening layer of secretions prevents this contact
and dilutes the anesthetic solution. The antimuscarinic drugs dry the airway by decreas-
ing salivary and mucus secretion. The antisialogogue most commonly used is glycopyrro-
late, but atropine and scopolamine are also used. Atropine and scopolamine are tertiary
amines and, therefore, cross the blood/brain barrier. Administration of atropine (0.3-0.6
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Table 2. Sedatives used for awake fiberoptic intubation.
Pharmacological Onset Side
Sedatives actions Dose time Duration effects
Benzodiazepines:
Midazolam
Diazepam
Lorazepam
Buytyrophenones:
Droperidol
Narcotics:
Sedation.
Anterograde
amnesia.
Antiepileptic.
IV, IM=5-7 mg IV=1-3 min
(0.075 mg/kg) IM=15-30 min
IV=2.7 mg
(0.03-0.1 mg/kg),
IM=not
recommended
PO=3-11 mg
(0.05-0.15 mg/kg)
IV, IM, PO= IV=5-20 min
1-4 mg IM=30-120 min
PO=60-120 min
IV, IM=2 hr Respiratory
impairment in
high doses
Respiratory
impairment in
high doses.
IV and IM are
painful.
Thrombophlebitis
IV=4-6 hr Respiratory
IM, PO=8 hr impairment
in high doses
Sedation.
Antiemitic.
Indifference.
IV, IM=0.625-10 mg IV, IM=5-10 min IV, IM=6-12 hr Dysphoria.
Extrapyramidal
symptoms.
Mild alpha-
adrenergic
antagonists
Prolonged
emergence from
anesthesia.
Analgesia.
Sedation.
IV, IM, SQ=2-10 mg
IV, IM=50-100 pg
IV=5-10 min
IM=30-60 min
SQ=30-90 min
1-6 hr Respiratory
depression.
Bronchospasm.
Chest wall
rigidity.
Bradycardia.
Vomiting.
Hypotension.
IV=2 min IV, IM= Similar to
IM=10-15 min 30-45 min morphine.
Bronchospasm
and hypotension
are less common.
Morphine
Fentanyl
Dosages and times quoted are broad generalities.
IM, intramuscular; IV, intravenous; PO, orally; SQ, subcutaneous.
From Reed, A.P. and Han, D.G. Clinical management of the airway (with permission).
544Walsh and Shorten: Preparing an awakefiberoptic intubation
mg IV) causes significant tachycardia. Glycopyrrolate is a quaternary ammonium com-
pound and, therefore, does not cross the normal blood brain barrier and does not cause
sedation. Oral absorption ofglycopyrrolate is poor and erratic with a bio-availability of 5
percent [10]. It should be administered intravenously, (0.1-0.2 mg). Its onset time is 1-4
minutes, and its duration ofeffect is 2-4 hours. Side effects ofglycopyrrolate occur rarely
but include cardiac arrhythmias, urinary retention, relaxation oflower esophageal sphinc-
ter tone, mydriasis and cycloplegia.
Sedation
Very anxious patients may benefit from an oral anxiolytic agent administered pre-
operatively. It should be borne in mind, however, that patients with significant airway
compromise may require conscious muscle tone to maintain airway patency. In the awake
patient, upper airway patency is dependent in part on pharyngeal reflexes, which activate
pharyngeal dilator muscles during inspiration. The effectiveness of these reflexes, in
maintaining airway patency is compromised by sleep, sedative agents and general anes-
thesia [11]. Sedation should be administered intravenously by the assistant at the time of
endoscopy. The objective is to achieve anxiolysis without rendering the patient un-coop-
erative. The heavily-sedated patient will not co-operate well, may be unable to maintain
adequate ventilation or even aspirate pharyngeal contents.
Agents with rapid onset and offset of effect are ideal. The choice of sedative agents
includes benzodiazepines, opioids and butyrophenones (Table 2). The commonly used
benzodiazepines are midazolam, diazepam and lorazepam. Midazolam is the most com-
monly used because ofits rapid onset, short half-life and its ability toprovide sedation and
anterograde amnesia. Administered in increments of 0.25 mg, its effect are seen in three
minutes. Unwanted effects include drowsiness, cardio-respiratory depression and, rarely,
ataxia [12]. Lorazepam possesses a three-hydroxy substitution on the benzodiazepine
nucleus and, therefore, is much less lipophilic than midazolam [12]. It has a long onset
time (20-40 minutes) when given intravenously, and it has an elimination half-life of 10-
14 hours.
Diazepam is poorly soluble in water, and the solvent (40 percent propylene glycol, 10
percent ethyl alcohol, 5 percent sodium benzoate and 1.5 percent alcohol) can cause dis-
comfort on injection and add to patient anxiety. Diazepam metabolites, desmethyl-
diazepam and oxazepam have sedative effects and have reported half-lives of48-96 hours.
When benzodiazepines are administered, it is prudent to have flumazenil available should
inadvertent overdose occur. Flumazenil at doses of8-15 pg/kg reverses the sedative effects
of the benzodiazepines but can cause convulsions in chronic users [13]. Its onset time is
less than 5 minutes, and its duration ofeffect between 1 to 3.5 hours [12].
In addition to sedation, opioids provide analgesia, depress laryngeal reflexes and are
antitussive. Side-effects include respiratory depression and euphoria [14]. Again, the ideal
choice in this group is fentanyl, which is a rapid acting and short duration agent. Fentanyl
administered in increments of 10 pg is very effective for"conscious sedation." Its sedative
effect is seen within one minute. Opioid-induced respiratory depression can be easily
reversed with naloxone 1-5 pg/kg. Opioid rigidity is not a problem when fentanyl is
administered in these low doses.
Droperidol (30-50 pg/kg) can be used alone or in combination with fentanyl. It is
given in doses of30-50 pg/kg. Although the patient may appear calm and pain-free, many
report a feeling of mental restlessness and agitation not apparent to the observer: the
"locked-in" syndrome [12].
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Table 3. Local anesthetic agents used for upper airway anesthetic.
Agent Preparation Uses Maximum dose
Lidocaine 0.5%, 1%, 2% Infiltration. 3-5 mg/kg
hydrochloride Transcricoid.
solution. Nerve blocks.
Gargle.
4% hydrochloride Nebulization.
solution. Topical to oropharynx.
1% ointment. Topical to mouth and
10% spray. oropharynx
Lubricant on
2% gel. nasopharyngeal airways.
Cocaine 4% solution. Topical nasal 3 mg/kg
10% solution application
Benzocaine 100 mg lozenge Oral cavity anesthesia 1.5 mg/kg
LOCAL ANESTHESIA
For the purpose ofanesthetizing the upper airway, it can be thought of as having four
parts:
1. Nasal cavity and nasopharynx.
2. Oral cavity and oropharynx
3. Larynx above vocal cords.
4. Larynx below vocal cords.
Adriani [15] summarized the principles and guidelines for the safe use of topical
anesthetics. It is essential to know the optimum effective concentration of each drug, the
rapidity of action, the recommended maximum safe dose, the rate of absorption and the
appropriate technique of application. The most frequently used agents are lidocaine and
cocaine, but the use oftetracaine and benzocaine are also well described [16] (Table 3).
Lidocaine is available as a clear colorless 0.5/1.0/1.5/2 percent solution for injection
with or without epinephrine (1 in 200,000), a gel containing 21.4 mg/ml of lidocaine, a
five-percent ointment, a 10 percent spray and a 4 percent viscous solution. Maximum rec-
ommended doses for application topically to the respiratory tract is 200-250 mg (3-4
mg/kg).
Lidocaine (5-10 mg/kg), used during topical application of local anesthetic to the
upper airway results in plasma concentrations well below those that cause symptoms of
toxicity (toxic level, 6 pg/ml ) [17]. Symptoms of severe lidocaine toxicity include con-
vulsions, respiratory failure and circulatory collapse. The onset of action oftopical appli-
cation of lidocaine is 3-5 minutes with a duration of action of 15-30 minutes. Lidocaine
used for specific nerve blocks has a more rapid onset, with durations of anesthesia of 75
minutes using a plain 1 percent solution and 400 minutes when using a 1 percent solution
with 1/200,000 epinephrine. Airway anesthesia at the time ofextubation may be desirable,
hence these time-scales should be borne in mind [4]. Allergic reactions to the amide local
anaesthetic agents are extremely rare [4]. Cocaine is an ester local anesthetic, which is
commercially available as a 1-4 percent solution and as a non-proprietary paste ofvarying
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concentrations. Applied topically, its duration of action is 20-30 minutes (its toxic dose is
3 mg/kg). Cocaine's vasoconstrictive action results from interference with the re-uptake of
catecholamines by adrenergic nerve endings. It should be used cautiously (or avoided) in
patients with hypertension, angina, thyrotoxicosis or who are taking MAOIs.Allergic reac-
tions occur occasionally, but side effects are predominately correlated with excessive plas-
ma concentrations. A 3:1 volume mixture of 4 percent lidocaine and 1 percent phenyle-
phrine provides both topical anesthesia and mucosal vasoconstriction ofthe nasal mucosa.
The nasal cavity's sensory innervation is via the sphenopalatine ganglia and the ante-
rior ethmoidal nerve. The sphenopalatine ganglion is situated in the pterygopalatine fossa
posterior to the middle turbinate. It is covered by a 1-5 mm layer ofconnective tissue and
mucosa. If the nasal septum is deviated, it is important to choose the more patent nares.
The nasal mucosa can be anesthetized with one spray delivery of 10 percent lido-
caine. Alternatively, three long cotton-tipped pledgets soaked in 4 percent cocaine or the
lidocaine/phenlyephrine mixture can be painted methodically along the nasal mucosa and
then left for 10 minutes. The nasal passage can be gently dilated with soft nasopharyngeal
airways of increasing diameter that have been lubricated with lidocaine gel (2 percent).
Oxymetazoline is apotent sympathomimetic drug available as a0.1 percent hydrochloride
(2-3 ml per nostril) solution, which can be easily mixed with lidocaine 2 percent.
Instrumentation of the airway can cause fluctuations in blood pressure and heart rate.
Using nebulizers to the entire airway with local anesthetic solution can minimize these.
The nebulizer is filled with 5 ml of4 percent lidocaine, and the oxygen flow rate is kept
below 6 liters per minute. Higher flow rates create smaller droplets (<30 microns) that
travel further distally into the bronchial tree and increase the rate of systemic absorption
[18]. Largerdroplets (>60 microns) are preferred because they precipitate out in the prox-
imal airway where the topical anesthesia is required. It is important to allow adequate time
(15-20 minutes) for inhalational anesthesia to be effective and to sit the patient upright
during nebulization.
ORAL CAVITY
Techniques for application oflocal anesthetic to the oral cavity include, a benzocaine
lozenge (100 mg) 30 minutes prior to the procedure, or by using lidocaine 10 percent
spray, or by gargling viscous lidocaine 2 percent. Lidocaine ointment 2.5 percent may be
pasted on the base of the tongue and tonsillar pillars to augment the sprays. A lingual
nerve block may be performed in those with a particularly active gag reflex.
LARYNX AND TRACHEA
The two most commonly used nerve blocks in our practice are the superior laryngeal
nerve block and transcricoid instillation. The superior laryngeal nerve is a division ofthe
vagus and courses inferiorly medial to the carotid artery. At the level of the hyoid bone it
pierces the thyrohyoid membrane and divides into internal and external branches. It can
be blocked topically via the mouth or by infiltration through the anterior aspect of the
neck. The success rate of this nerve block has been reported to be as high as 92 percent
[19]. Internally, the nerve passes through the piriform fossa and lies submucosally and can
be easily blocked by holding pledgets of local anaesthetic in the fossa with Krause for-
ceps. This is done only after the tongue and oropharynx have been anesthetized. The
patient is placed in the sitting position and asked to open the mouth wide and protrude the
tongue. The tongue is grasped with a piece ofgauze or depressed with a spatula.
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The Krause forceps with lidocaine 4 percent soaked wool is placed firmly in the pir-
iform fossa and held there for 5 minutes, and this is then repeated on the opposite side.
The external approach to the superior laryngeal nerve is slightly more uncomfortable
for the patient. The patient is placed in the supine position, with the head extended. The
hyoid bone and the superior aspect ofthe thyroid cartilage are identified. Three approach-
es have been described [16]. The first uses the cornu ofthe hyoid bone as its point ofskin
entry. The second uses the cornu of the thyroid cartilage, but both of these approaches
require deep palpation, particularly in overweight patients. The third method uses the mid-
line superior notch of the thyroid cartilage (Adam's apple) as the main landmark. From
this point the upper border ofcartilage is traced 2 cm laterally. Using a 2.5 cm, 25 gauge
needle, the thyrohyoid membrane is pierced at this point in a posterior-cephalad direction
to 1-1.5 cm depth. Following a negative aspiration test, 2 ml of lidocaine 2 percent is
injected, and this is repeated on the opposite side. It is important to note that this block
may require 5-10 minutes for full effect. Side-effects of this block are rare; the most
important being hematoma formation (the superior laryngeal artery courses with the
nerve). Othercomplications include perforation ofthepharynx and intra-arterial injection.
Contraindications are few but include local infection and local tumor.
TRANSLARYNGEAL INSTILLATION
Local anesthetic solution can also be injected through the cricothyroid membrane.
The patient is placed in the supine position with the neck extended. Patients should be
warned ofthe vigorous coughing this block causes. This coughing enhances the spread of
local anesthetic. A 25 gauge needle on a 3 ml syringe is inserted through the membrane
in the midline. Once correct placement is confirmed by aspiration ofair, 2 ml oflidocaine
2 percent is injected quickly. Relative contraindications to this block include local malig-
nancy, cervical spine instability and the presence ofa goiter. The use ofa catheter overthe
needle has been employed in an attempt to reduce risk oflaryngeal trauma.
SPRAY AS YOU GO
This technique uses the working channel of the bronchoscope to anesthetize the
supra-glottic structures and vocal cords. Ovassapian suggests using an epidural catheter
(internal diameter 0.5-1.0 mm) in the channel [20]. Under direct vision, targeted areas are
sprayed with 0.2-1.0 ml of lidocaine 2 percent. The endoscopist then waits 30 seconds
before advancing further. This method is ideal forpatients at risk ofaspirating gastric con-
tents because the local anesthetic is applied only seconds before the intubation is accom-
plished, allowing the patient to maintain the airway reflexes as long as possible.
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